Rule 8.1- Cobra Bio-manufacturing plc-Amendment
December 16 2009 - 11:55AM
UK Regulatory
TIDMCBF
RNS Number : 2536E
Recipharm AB
16 December 2009
CORRECTION This corrects the 8.3 announcement made on 16 December at 13.50 as
RNS NO 2277E including disclosures under section s 2a and 2b. The full corrected
announcement is given below
FORM 8.1
DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES
FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
(Rules 8.1(a) and (b)(i) of the Takeover Code)
1. KEY INFORMATION
+------------------------------------+------------------------------------------------------+
| Name of person dealing (Note 1) | Recipharm AB |
+------------------------------------+------------------------------------------------------+
| Company dealt in | Cobra Biomanufacturing plc |
| | |
+------------------------------------+------------------------------------------------------+
| Class of relevant security to | Ordinary Shares |
| which the dealings being disclosed | |
| relate (Note 2) | |
+------------------------------------+------------------------------------------------------+
| Date of dealing | 16 December 2009 |
+------------------------------------+------------------------------------------------------+
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
+------------------------------------+--------------------------+----------------------------+
| | Long | Short |
+------------------------------------+--------------------------+----------------------------+
| | Number | Number |
| | (%) | (%) |
+------------------------------------+--------------------------+----------------------------+
| (1) Relevant securities | 19450000 | |
| | (43.87%) | |
+------------------------------------+--------------------------+----------------------------+
| (2) Derivatives (other than | | |
| options) | | |
| | | |
+------------------------------------+--------------------------+----------------------------+
| (3) Options and agreements to | | |
| purchase/sell | | |
| | | |
+------------------------------------+--------------------------+----------------------------+
| Total | | |
| | | |
+------------------------------------+--------------------------+----------------------------+
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
+------------------------------------+--------------------------+----------------------------+
| Class of relevant security: | Long | Short |
| | | |
+------------------------------------+--------------------------+----------------------------+
| | Number | Number |
| | (%) | (%) |
+------------------------------------+--------------------------+----------------------------+
| (1) Relevant securities | | |
| | | |
+------------------------------------+--------------------------+----------------------------+
| (2) Derivatives (other than | | |
| options) | | |
| | | |
+------------------------------------+--------------------------+----------------------------+
| (3) Options and agreements to | | |
| purchase/sell | | |
| | | |
+------------------------------------+--------------------------+----------------------------+
| Total | | |
| | | |
+------------------------------------+--------------------------+----------------------------+
(c) Rights to subscribe (Note 3)
+------------------------------------+------------------------------------------------------+
| Class of relevant security: | Details |
| | |
+------------------------------------+------------------------------------------------------+
| Ordinary Shares | Convertible Loan note with right to convert into |
| | 18000000 shares. Total holding including shares |
| | acquired would then be 37450000 being approx 60.07% |
| | of then issued share capital |
+------------------------------------+------------------------------------------------------+
3. DEALINGS (Note 4)
(a) Purchases and sales
+------------------------------+-----------------------------+-------------------------------+
| Purchase/sale | Number of securities | Price per unit (Note 5) |
| | | |
+------------------------------+-----------------------------+-------------------------------+
| | | |
+------------------------------+-----------------------------+-------------------------------+
(b) Derivatives transactions (other than options)
+-----------------+--------------------+----------------------------+-------------------------+
| Product name, | Long/short (Note | Number of securities (Note | Price per unit (Note 5) |
| e.g. CFD | 6) | 7) | |
+-----------------+--------------------+----------------------------+-------------------------+
| | | | |
+-----------------+--------------------+----------------------------+-------------------------+
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
+-----------------+--------------+-----------------+----------+------------+---------+---------------+
| Product name, | Writing, | Number of | Exercise | Type, e.g. | Expiry | Option money |
| e.g. call | selling, | securities to | price | American, | date | paid/received |
| option | purchasing, | which the | | European | | per unit |
| | varying etc. | option relates | | etc. | | (Note 5) |
| | | (Note 7) | | | | |
+-----------------+--------------+-----------------+----------+------------+---------+---------------+
| | | | | | | |
+-----------------+--------------+-----------------+----------+------------+---------+---------------+
(ii) Exercising
+------------------------------+-----------------------------+-------------------------------+
| Product name, e.g. call | Number of securities | Exercise price per unit (Note |
| option | | 5) |
+------------------------------+-----------------------------+-------------------------------+
| | | |
+------------------------------+-----------------------------+-------------------------------+
(d) Other dealings (including new securities) (Note 4)
+------------------------------+-----------------------------+-------------------------------+
| Nature of transaction (Note | Details | Price per unit (if |
| 8) | | applicable) (Note 5) |
| | | |
+------------------------------+-----------------------------+-------------------------------+
| | | |
+------------------------------+-----------------------------+-------------------------------+
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
+------------------------------------------------------------------------------------------+
| Full details of any agreement, arrangement or understanding between the person |
| disclosing and any other person relating to the voting rights of any relevant securities |
| under any option referred to on this form or relating to the voting rights or future |
| acquisition or disposal of any relevant securities to which any derivative referred to |
| on this form is referenced. If none, this should be stated. |
+------------------------------------------------------------------------------------------+
| |
+------------------------------------------------------------------------------------------+
Is a Supplemental Form 8 attached? (Note 9)YES/NO
+---------------------------------------------------+---------------------------------------+
| Date of disclosure | 16 December 2009 |
+---------------------------------------------------+---------------------------------------+
| Contact name | Harry Dutson |
+---------------------------------------------------+---------------------------------------+
| Telephone number | 0870 122 5432 |
+---------------------------------------------------+---------------------------------------+
| Name of offeree/offeror with which associated | |
+---------------------------------------------------+---------------------------------------+
| Specify category and nature of associate status | |
| (Note 10) | |
+---------------------------------------------------+---------------------------------------+
Notes
The Notes on Form 8.1 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
DCCEAKAKFSFNFFE
Cobra Bio-manufacturing (LSE:CBF)
Historical Stock Chart
From May 2024 to Jun 2024
Cobra Bio-manufacturing (LSE:CBF)
Historical Stock Chart
From Jun 2023 to Jun 2024
